NGL COVID-19 刺突蛋白亲和填料
新型 SARS CoV-2特异性亲和填料能够实现高纯度捕获步骤，减少工艺时间，并提高COVID-19疫苗商业化生产的产量。
HIGH PERFORMANCE
SARS CoV-2 specific affinity resin for the purification of COVID-19 vaccines
针对SARS CoV-2刺突蛋白纯化的新型亲和填料，用于疫苗开发和生产
The result of close work with Navigo Proteins on the ligand development and partnership with Purolite Life Sciences on Praesto®agarose bead technology, the new NGL COVID-19 Spike Protein Affinity Resin from Repligen binds the SARS CoV-2 Spike Protein receptor binding domain (RBD) to yield exceptional purity in a single chromatography step. The product meets all the expected requirements of a high-performance resin, including very high selectivity, high dynamic binding capacities and caustic stability over multi-cycle use.
The resin is available in off-the shelf, pre-packed and pre-qualified OPUS® Columns for rapid implementation as well as in loose resin formats.
HIGH PERFORMANCE
Single-step affinity chromatography with high resolution
NGL COVID-19刺突蛋白亲和填料的主要特点包括：
- 含有SARS-CoV-2刺突蛋白RBD的产品的单步纯化*
- 兼容 0.1N NaOH CIP
- 高结合载量**
HIGH PERFORMANCE
Optimized bead chemistry delivers exceptional purity
NGL COVID-19刺突蛋白亲和填料可在单个纯化步骤中获得>90%的纯度。
以HEK293细胞表达的SARS-CoV-2刺突蛋白受体结合结构域（RBD）以NGL COVID-19刺突蛋白亲和填料纯化的SDS-PAGE凝胶图。
SPEED TO MARKET
Available pre-packed in OPUS® Columns for quick deployment
NGL COVID-19刺突蛋白亲和填料可以经质量确认的现货OPUS® 预装柱形式提供，以简化并加快GMP使用，同时，也提供“散装”填料形式。
使用预装、预质量确认的OPUS®层析柱，可使您在数周内从开发进入生产规模。
解决方案
客户至上。
Repligen DNA 为您提供支持。我们的目标是提供卓越的客户体验，并为所有 Repligen 产品和服务高效成功的采用及实施提供支持。
- Field Application Support
- 客户服务
- 现场服务工程师
